Quoted from http://www.fiercebiotech.com/story/fda-staffers-endorse-gtcs-transgenic-anti-clotting-drug/2009-01-07?utm_medium=nl&utm_source=internal&cmp-id=EMC-NL-FB&dest=FB:
FDA staffers endorse transgenic anti-clotting drug - FierceBiotech
The field of transgenics--developing therapies in genetically engineered animals--just got a big boost from staffers at the FDA. Regulators said that Framingham, MA-based GTC BioTherapeutics's drug ATryn, an anti-clotting treatment produced in goats, appeared to be safe and effective. The recommendation was released in documents made available ahead of an expert advisory committee meeting on Friday.
...GTC is one of a handful of companies out to demonstrate that it can produce a less-expensive stream of therapeutics from transgenic animals, harvesting drugs through their milk.
Other references on transgenic or ATryn include:
Xconomy Report on Genetically Engineered Goats
![Reblog this post [with Zemanta]](http://img.zemanta.com/reblog_e.png?x-id=8776a4f7-483b-4a94-9ac1-f37d3732ba23)
